Politician trade (House)

Boston Scientific (BSX): Rep. Lisa C. McClain (MI09) disclosed a purchase $1K–$15K

Rep. Lisa C. McClain (MI09) disclosed a purchase of Boston Scientific in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
245 days
Disclosure lag
Traded
Dec 11, 2024
Disclosed
Aug 13, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 1, 2024InsiderOfficer sold ~$589K of BSX shares in the open market
  2. Nov 5, 2024Insider · 1 personInsiders: 2 sales (~$13.8M)
  3. Nov 8, 2024InsiderOfficer sold ~$2.68M of BSX shares in the open market
  4. Nov 21, 2024InsiderDirector sold ~$447K of BSX shares in the open market
  5. Nov 25, 2024InsiderOfficer sold ~$1.25M of BSX shares in the open market
  6. Nov 27, 2024InsiderOfficer sold ~$121K of BSX shares in the open market
  7. Dec 2, 2024InsiderOfficer sold ~$634K of BSX shares in the open market
  8. Dec 3, 2024InsiderOfficer purchased ~$4.5K of BSX shares in the open market
  9. Dec 10, 2024InsiderOfficer sold ~$1.8K of BSX shares in the open market

What came next

  1. Dec 20, 2024FDARecall: AXIOS Stent and Delivery System 10mmx10mm UPN: M00553740
  2. Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 10mmx10mm UPN: M00553540
  3. Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 20mmx10mm UPN: M00553560
  4. Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 15mmx10mm UPN: M00553550
  5. Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 15mmx10mm UPN: M00553650
  6. Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 15mmx15mm UPN: M00553670
  7. Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 6mmx8mm UPN: M00553680
  8. Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 10mmx10mm UPN: M00553640
  9. Jan 2, 2025InsiderOfficer sold ~$371K of BSX shares in the open market
  10. Jan 3, 2025Insider · 3 peopleInsiders: 3 sales (~$1.7M)
  11. Feb 3, 2025Insider · 1 personInsiders: 2 sales (~$1.8M)
  12. Feb 6, 2025FDAFDA device clearance: Resolution Clip (M00522600); Resolution Clip (M00522601); Resolution Clip (M00522602); Resolution Clip (M00522610); Resolution Clip (M00522611); Resolution Cli…
  13. Feb 7, 2025InsiderOfficer sold ~$685K of BSX shares in the open market
  14. Feb 11, 2025InsiderDirector sold ~$1.27M of BSX shares in the open market
  15. Feb 12, 2025Insider · 3 peopleInsiders: 3 sales (~$3.6M)
  16. Feb 13, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  17. Feb 14, 2025InsiderOfficer sold ~$128K of BSX shares in the open market
  18. Feb 18, 2025Insider · 2 peopleInsiders: 3 sales (~$2.1M)
  19. Feb 19, 2025Insider · 3 peopleInsiders: 3 sales (~$7.6M)
  20. Feb 21, 2025InsiderOfficer sold ~$505K of BSX shares in the open market
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

Other recent filings by Rep. Lisa C. McClain (MI09)

The full history of Rep. Lisa C. McClain (MI09) is on the profile page.

How this filing works

Explore the data

Common questions

Which member of Congress traded Boston Scientific (BSX) stock, and how much?

Rep. Lisa C. McClain (MI09) disclosed a purchase of Boston Scientific in the $1K–$15K range. Reported range, not an exact amount, Spouse account.

When did it happen, and when was it made public?

Traded: Dec 11, 2024. Disclosed: Aug 13, 2025. That is 245 days between the two dates.

Why is the amount a range and not an exact figure?

Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.

Where does this information come from?

From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Boston Scientific recently?

For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the BSX page.

Does this mean BSX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data